banner investors

Contactform

You can leave a message.
We will contact you as soon as possible
.
Please type your full name.

Invalid email address.

Invalid Input

Invalid Input

Antispam

Latest news

showCyTuVax has shown the strength of its vaccine adjuvant technology in the Phase 2 clinical trial of a vaccine for hepatitis B non-responders
Press release 17-06-2019

Where we are

About us

CyTuVax B.V.
Oxfordlaan 55
6229 EV Maastricht
The Netherlands

+31-433881424
Contact us by email